LH/Mav |
aorta weight to body weight ratio |
streptozotocin (75 mg/kg) then hydralazine (75 mg/kg/d) (for 56 days) and controlled hydralazine content drinking water (15 mg/kg/d) (for 56 days) and reserpine (0.75 ml/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
aorta mass |
male |
112 days
| 7 |
|
12.5 |
mg/100g |
0.5 |
1.32 |
post excision weight measurement |
0.0 |
|
0 |
|
|
102691 |
2703 |
MW |
glomerular transcapillary hydraulic pressure gradient |
nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
blood molecular composition trait |
male |
0 days
| 8 |
|
49.0 |
mmHg |
1.0 |
2.83 |
servo-null micropipette transducer method |
0.0 |
5/6 nephrectomy |
28 |
days |
|
101018 |
2561 |
MW |
efferent arteriolar plasma protein concentration |
nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
blood total protein amount |
male |
0 days
| 8 |
|
8.0 |
g/dl |
0.2 |
0.57 |
micropuncture fluid collection |
0.0 |
5/6 nephrectomy |
28 |
days |
|
101024 |
2561 |
MW |
afferent arteriolar resistance |
nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
kidney blood vessel physiology trait |
male |
0 days
| 8 |
|
1.0 |
x 10E10 dyne x s/cm5 |
0.1 |
0.28 |
servo-null micropipette transducer method |
0.0 |
5/6 nephrectomy |
28 |
days |
|
101033 |
2561 |
MW |
urine sodium excretion rate |
nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
urine sodium amount |
male |
0 days
| 7 |
|
1.78 |
mEq/d |
0.28 |
0.74 |
flame photometry |
0.0 |
5/6 nephrectomy |
28 |
days |
|
101050 |
2561 |
LH/Mav |
renal vascular resistance to kidney weight ratio |
hydralazine (75 mg/kg/d) (for 63 days) and controlled hydralazine content drinking water (15 mg/kg/d) (for 63 days) and reserpine (0.75 mg/kg/d) (for 63 days) then ketamine (20 mg/kg) and thiobutabarbital (75 mg/kg) |
Issiakhem M, et al., J Cardiovasc Pharmacol. 2008 Mar;51(3):280-5. doi: 10.1097/FJC.0b013e31816299a5. |
kidney blood vessel physiology trait |
male |
84 days
| 10 |
SBP/RBF |
27.0 |
ml/min/g/mmHg |
2.0 |
6.32 |
ultrasonic flowmeter |
0.0 |
|
0 |
|
|
102869 |
2761 |
MW |
systolic blood pressure |
right nephrectomy (for 84 days) then reserpine (5 mg/l) (for 28 days) and hydralazine (80 mg/l) (for 28 days) and controlled hydralazine content drinking water (25 mg/l) (for 28 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
arterial blood pressure trait |
male |
0 days
| 10 |
undefined |
131.1 |
mmHg |
4.0 |
12.65 |
tail cuff plethysmography |
0.0 |
~5/6 to 7/8 nephrectomy |
84 |
days |
|
100870 |
2523 |
LH/Mav |
plasma creatinine level |
streptozotocin (75 mg/kg) then hydralazine (75 mg/kg/d) (for 56 days) and controlled hydralazine content drinking water (15 mg/kg/d) (for 56 days) and reserpine (0.75 ml/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
blood creatinine amount |
male |
112 days
| 7 |
|
0.59 |
mg/dl |
0.02 |
0.04 |
plasma creatinine analysis |
0.0 |
|
0 |
|
|
102679 |
2703 |
LH/Mav |
renal blood flow rate to kidney weight ratio |
hydralazine (75 mg/kg/d) (for 63 days) and controlled hydralazine content drinking water (15 mg/kg/d) (for 63 days) and reserpine (0.75 mg/kg/d) (for 63 days) then ketamine (20 mg/kg) and thiobutabarbital (75 mg/kg) |
Issiakhem M, et al., J Cardiovasc Pharmacol. 2008 Mar;51(3):280-5. doi: 10.1097/FJC.0b013e31816299a5. |
renal blood flow trait |
male |
84 days
| 10 |
|
4.7 |
ml/min/g |
0.3 |
0.95 |
ultrasonic flowmeter |
0.0 |
|
0 |
|
|
102856 |
2761 |
MW |
afferent arteriolar plasma flow rate |
nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
kidney plasma flow trait |
male |
0 days
| 8 |
|
224.0 |
nl/min |
18.0 |
50.91 |
servo-null micropipette transducer method |
0.0 |
5/6 nephrectomy |
28 |
days |
|
101006 |
2561 |
MW |
body weight |
right nephrectomy (for 112 days) then reserpine (5 mg/l) (for 56 days) and hydralazine (80 mg/l) (for 56 days) and controlled hydralazine content drinking water (25 mg/l) (for 56 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
body mass |
male |
0 days
| 10 |
|
244.3 |
g |
17.2 |
54.39 |
body weighing method |
0.0 |
~5/6 to 7/8 nephrectomy |
112 |
days |
|
100828 |
2523 |
MW |
blood urea nitrogen level |
right nephrectomy (for 112 days) then reserpine (5 mg/l) (for 56 days) and hydralazine (80 mg/l) (for 56 days) and controlled hydralazine content drinking water (25 mg/l) (for 56 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
blood urea nitrogen amount |
male |
0 days
| 10 |
|
73.6 |
mg/dl |
4.3 |
13.6 |
blood urea nitrogen analysis |
0.0 |
~5/6 to 7/8 nephrectomy |
112 |
days |
|
100842 |
2523 |
MW |
hematocrit |
right nephrectomy (for 56 days) then reserpine (5 mg/l) and hydralazine (80 mg/l) and controlled hydralazine content drinking water (25 mg/l) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
erythrocyte quantity |
male |
0 days
| 10 |
|
48.4 |
% |
1.4 |
4.43 |
hematocrit analysis |
0.0 |
~5/6 to 7/8 nephrectomy |
56 |
days |
|
100849 |
2523 |
MW |
systolic blood pressure |
right nephrectomy (for 56 days) then reserpine (5 mg/l) and hydralazine (80 mg/l) and controlled hydralazine content drinking water (25 mg/l) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
arterial blood pressure trait |
male |
0 days
| 10 |
undefined |
180.6 |
mmHg |
7.7 |
24.35 |
tail cuff plethysmography |
0.0 |
~5/6 to 7/8 nephrectomy |
56 |
days |
|
100863 |
2523 |
SHR/N-cp |
plasma renin activity level |
standard diet (between 28 and 42 days) then controlled carbohydrate content diet (54 %) (between 140 and 154 days) then controlled hydralazine content drinking water (30 mg/l) (between 84 and 98 days) and hydralazine (50 mg/l) (between 84 and 98 days) and reserpine (4 mg/l) (between 84 and 98 days) |
Velasquez MT, et al., Hypertension. 1997 Nov;30(5):1232-7. |
renin activity |
male |
140 days-168 days |
8 |
|
38.0 |
ng/ml/h |
2.0 |
5.66 |
radioimmunoassay |
0.0 |
|
0 |
|
|
101534 |
2601 |
MW |
body weight |
right nephrectomy (for 56 days) then reserpine (5 mg/l) and hydralazine (80 mg/l) and controlled hydralazine content drinking water (25 mg/l) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
body mass |
male |
0 days
| 10 |
|
276.6 |
g |
7.4 |
23.4 |
body weighing method |
0.0 |
~5/6 to 7/8 nephrectomy |
56 |
days |
|
100800 |
2523 |
LH/Mav |
both kidneys wet weight to body weight ratio |
streptozotocin (75 mg/kg) then hydralazine (75 mg/kg/d) (for 56 days) and controlled hydralazine content drinking water (15 mg/kg/d) (for 56 days) and reserpine (0.75 ml/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
kidney mass |
male |
112 days
| 7 |
|
8.05 |
g/kg |
0.24 |
0.63 |
post excision weight measurement |
0.0 |
|
0 |
|
|
102697 |
2703 |
MW |
mean proximal tubular hydraulic pressure |
nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
blood molecular composition trait |
male |
0 days
| 8 |
|
16.0 |
mmHg |
1.0 |
2.83 |
servo-null micropipette transducer method |
0.0 |
5/6 nephrectomy |
28 |
days |
|
101012 |
2561 |
MW |
efferent arteriolar hydraulic pressure |
nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
blood molecular composition trait |
male |
0 days
| 8 |
|
21.0 |
mmHg |
1.0 |
2.83 |
servo-null micropipette transducer method |
0.0 |
5/6 nephrectomy |
28 |
days |
|
101015 |
2561 |
MW |
body weight |
nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
body mass |
male |
0 days
| 8 |
|
233.0 |
g |
4.0 |
11.31 |
body weighing method |
0.0 |
5/6 nephrectomy |
28 |
days |
|
100985 |
2561 |
MW |
hematocrit |
nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
erythrocyte quantity |
male |
0 days
| 8 |
|
36.0 |
% |
1.0 |
2.83 |
hematocrit analysis |
0.0 |
5/6 nephrectomy |
28 |
days |
|
100988 |
2561 |
MW |
hematocrit |
right nephrectomy (for 112 days) then reserpine (5 mg/l) (for 56 days) and hydralazine (80 mg/l) (for 56 days) and controlled hydralazine content drinking water (25 mg/l) (for 56 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
erythrocyte quantity |
male |
0 days
| 10 |
|
45.8 |
% |
0.7 |
2.21 |
hematocrit analysis |
0.0 |
~5/6 to 7/8 nephrectomy |
112 |
days |
|
100856 |
2523 |
MW |
efferent colloid osmotic pressure |
nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
blood molecular composition trait |
male |
0 days
| 8 |
|
32.0 |
mmHg |
2.0 |
5.66 |
micropuncture fluid collection |
0.0 |
5/6 nephrectomy |
28 |
days |
efferent arteriolar colloid osmotic pressure |
101030 |
2561 |
SHR/N-cp |
both kidneys wet weight to body weight ratio |
standard diet (between 28 and 42 days) then controlled carbohydrate content diet (54 %) (between 140 and 154 days) then controlled hydralazine content drinking water (30 mg/l) (between 84 and 98 days) and hydralazine (50 mg/l) (between 84 and 98 days) and reserpine (4 mg/l) (between 84 and 98 days) |
Velasquez MT, et al., Hypertension. 1997 Nov;30(5):1232-7. |
kidney mass |
male |
140 days-168 days |
8 |
|
1.83 |
g/kg |
0.31 |
0.88 |
post excision weight measurement |
0.0 |
|
0 |
|
|
101525 |
2601 |
SHR/N-cp |
kidney sclerotic glomeruli count to total glomeruli count ratio |
standard diet (between 28 and 42 days) then controlled carbohydrate content diet (54 %) (between 140 and 154 days) then controlled hydralazine content drinking water (30 mg/l) (between 84 and 98 days) and hydralazine (50 mg/l) (between 84 and 98 days) and reserpine (4 mg/l) (between 84 and 98 days) |
Velasquez MT, et al., Hypertension. 1997 Nov;30(5):1232-7. |
kidney glomerulus integrity trait |
male |
140 days-168 days |
8 |
|
4.0 |
% |
1.0 |
2.83 |
ex vivo light microscopy with histochemistry |
0.0 |
|
0 |
|
|
101528 |
2601 |
MW |
plasma renin activity level |
nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
renin activity |
male |
0 days
| 7 |
|
21.9 |
ng/ml/h |
2.5 |
6.61 |
radioimmunoassay |
0.0 |
5/6 nephrectomy |
28 |
days |
|
101046 |
2561 |
MW |
body weight |
right nephrectomy (for 84 days) then reserpine (5 mg/l) (for 28 days) and hydralazine (80 mg/l) (for 28 days) and controlled hydralazine content drinking water (25 mg/l) (for 28 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
body mass |
male |
0 days
| 10 |
|
276.6 |
g |
7.4 |
23.4 |
body weighing method |
0.0 |
~5/6 to 7/8 nephrectomy |
84 |
days |
|
100807 |
2523 |
LH/Mav |
aorta weight to body weight ratio |
controlled hydrochlorothiazide content drinking water (15 mg/kg/d) (for 63 days) and hydralazine (75 mg/kg/d) (for 63 days) and reserpine (0.75 mg/kg/d) (for 63 days) then controlled sodium content drinking water (2 %) (for 8 days) |
Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b. |
aorta mass |
male |
119 days
| 7 |
|
15.8 |
mg/100g |
0.8 |
2.12 |
post excision weight measurement |
0.0 |
|
0 |
|
|
103418 |
2824 |
LH/Mav |
both kidneys wet weight to body weight ratio |
controlled hydrochlorothiazide content drinking water (15 mg/kg/d) (for 63 days) and hydralazine (75 mg/kg/d) (for 63 days) and reserpine (0.75 mg/kg/d) (for 63 days) then controlled sodium content drinking water (2 %) (for 8 days) |
Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b. |
kidney mass |
male |
119 days
| 7 |
|
7.3 |
g/kg |
0.09 |
0.24 |
post excision weight measurement |
0.0 |
|
0 |
|
|
103423 |
2824 |
MW |
glomerular filtration rate |
right nephrectomy (for 112 days) then reserpine (5 mg/l) (for 56 days) and hydralazine (80 mg/l) (for 56 days) and controlled hydralazine content drinking water (25 mg/l) (for 56 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
glomerular filtration trait |
male |
0 days
| 10 |
|
0.32 |
ml/min |
0.01 |
0.03 |
inulin analysis by liquid phase colorimetry |
0.0 |
~5/6 to 7/8 nephrectomy |
112 |
days |
|
100884 |
2523 |
MW |
systolic blood pressure |
right nephrectomy (for 112 days) then reserpine (5 mg/l) (for 56 days) and hydralazine (80 mg/l) (for 56 days) and controlled hydralazine content drinking water (25 mg/l) (for 56 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
arterial blood pressure trait |
male |
0 days
| 10 |
undefined |
149.4 |
mmHg |
8.3 |
26.25 |
tail cuff plethysmography |
0.0 |
~5/6 to 7/8 nephrectomy |
112 |
days |
|
100880 |
2523 |
LH/Mav |
heart left ventricle weight to body weight ratio |
streptozotocin (75 mg/kg) then hydralazine (75 mg/kg/d) (for 56 days) and controlled hydralazine content drinking water (15 mg/kg/d) (for 56 days) and reserpine (0.75 ml/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
heart left ventricle mass |
male |
112 days
| 7 |
|
24.2 |
mg/g |
0.3 |
0.79 |
post excision weight measurement |
0.0 |
|
0 |
|
|
102685 |
2703 |
MW |
single nephron glomerular filtration rate |
nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
glomerular filtration trait |
male |
0 days
| 8 |
|
63.6 |
nl/min |
5.2 |
14.71 |
micropuncture fluid collection |
0.0 |
5/6 nephrectomy |
28 |
days |
|
101000 |
2561 |
MW |
glomerular capillary hydraulic pressure |
nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
blood molecular composition trait |
male |
0 days
| 8 |
|
65.0 |
mmHg |
1.0 |
2.83 |
servo-null micropipette transducer method |
0.0 |
5/6 nephrectomy |
28 |
days |
|
101009 |
2561 |
MW |
single nephron filtration fraction |
nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
glomerular filtration trait |
male |
0 days
| 8 |
|
0.29 |
null |
0.02 |
0.06 |
micropuncture fluid collection |
0.0 |
5/6 nephrectomy |
28 |
days |
|
101003 |
2561 |
MW |
blood urea nitrogen level |
right nephrectomy (for 56 days) then reserpine (5 mg/l) and hydralazine (80 mg/l) and controlled hydralazine content drinking water (25 mg/l) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
blood urea nitrogen amount |
male |
0 days
| 10 |
|
53.9 |
mg/dl |
5.4 |
17.08 |
blood urea nitrogen analysis |
0.0 |
~5/6 to 7/8 nephrectomy |
56 |
days |
|
100835 |
2523 |
MW |
afferent arteriolar plasma protein concentration |
nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
blood total protein amount |
male |
0 days
| 8 |
|
5.7 |
g/dl |
0.1 |
0.28 |
micropuncture fluid collection |
0.0 |
5/6 nephrectomy |
28 |
days |
|
101021 |
2561 |
MW |
efferent arteriolar resistance |
nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
kidney blood vessel physiology trait |
male |
0 days
| 8 |
|
1.28 |
x 10E10 dyne x s/cm5 |
0.11 |
0.31 |
servo-null micropipette transducer method |
0.0 |
5/6 nephrectomy |
28 |
days |
|
101036 |
2561 |
SHR/N-cp |
serum glucose level |
standard diet (between 28 and 42 days) then controlled carbohydrate content diet (54 %) (between 140 and 154 days) then controlled hydralazine content drinking water (30 mg/l) (between 84 and 98 days) and hydralazine (50 mg/l) (between 84 and 98 days) and reserpine (4 mg/l) (between 84 and 98 days) |
Velasquez MT, et al., Hypertension. 1997 Nov;30(5):1232-7. |
blood glucose amount |
male |
140 days-168 days |
8 |
|
139.76 |
mg/dl |
29.04 |
82.14 |
serum glucose analysis |
0.0 |
|
0 |
|
|
101510 |
2601 |
MW |
glomerular filtration rate |
nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
glomerular filtration trait |
male |
0 days
| 8 |
|
0.61 |
ml/min |
0.08 |
0.23 |
inulin analysis by liquid phase colorimetry |
0.0 |
5/6 nephrectomy |
28 |
days |
|
100994 |
2561 |
LH/Mav |
heart left ventricle weight to body weight ratio |
controlled hydrochlorothiazide content drinking water (15 mg/kg/d) (for 63 days) and hydralazine (75 mg/kg/d) (for 63 days) and reserpine (0.75 mg/kg/d) (for 63 days) then controlled sodium content drinking water (2 %) (for 8 days) |
Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b. |
heart left ventricle mass |
male |
119 days
| 7 |
|
2.79 |
mg/g |
0.04 |
0.11 |
post excision weight measurement |
0.0 |
|
0 |
|
|
103413 |
2824 |
LH/Mav |
plasma triglyceride level |
streptozotocin (75 mg/kg) then hydralazine (75 mg/kg/d) (for 56 days) and controlled hydralazine content drinking water (15 mg/kg/d) (for 56 days) and reserpine (0.75 ml/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
blood triglyceride amount |
male |
112 days
| 7 |
|
1.58 |
mmol/l |
0.08 |
0.21 |
plasma triglyceride analysis |
0.0 |
|
0 |
|
|
102673 |
2703 |
MW |
plasma urea nitrogen level |
nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
blood urea nitrogen amount |
male |
0 days
| 8 |
|
21.42 |
mmol/l |
1.43 |
4.04 |
plasma urea nitrogen analysis |
0.0 |
5/6 nephrectomy |
28 |
days |
|
100991 |
2561 |
MW |
mean arterial blood pressure |
nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
arterial blood pressure trait |
male |
0 days
| 8 |
undefined |
107.0 |
mmHg |
3.0 |
8.49 |
vascular indwelling catheter method |
0.0 |
5/6 nephrectomy |
28 |
days |
|
100997 |
2561 |
MW |
afferent colloid osmotic pressure |
nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
blood molecular composition trait |
male |
0 days
| 8 |
|
19.0 |
mmHg |
0.4 |
1.13 |
micropuncture fluid collection |
0.0 |
5/6 nephrectomy |
28 |
days |
|
101027 |
2561 |
MW |
total arteriolar resistance |
nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
kidney blood vessel physiology trait |
male |
0 days
| 8 |
|
2.28 |
x 10E10 dyne x s/cm5 |
0.18 |
0.51 |
servo-null micropipette transducer method |
0.0 |
5/6 nephrectomy |
28 |
days |
|
101039 |
2561 |
MW |
glomerular capillary ultrafiltration coefficient |
nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
glomerular filtration trait |
male |
0 days
| 8 |
|
0.05 |
nl/(s x mmHg) |
0.0 |
0.01 |
micropuncture fluid collection |
0.0 |
5/6 nephrectomy |
28 |
days |
|
101042 |
2561 |
SHR/N-cp |
serum glucose level |
standard diet (between 28 and 42 days) then controlled carbohydrate content diet (54 %) (between 42 and 56 days) then controlled hydralazine content drinking water (30 mg/l) and hydralazine (50 mg/l) and reserpine (4 mg/l) |
Velasquez MT, et al., Hypertension. 1997 Nov;30(5):1232-7. |
blood glucose amount |
male |
70 days-98 days |
8 |
|
139.76 |
mg/dl |
14.52 |
41.07 |
serum glucose analysis |
0.0 |
|
0 |
|
|
101501 |
2601 |
SHR/N-cp |
serum glucose level |
standard diet (between 28 and 42 days) then controlled carbohydrate content diet (54 %) (between 112 and 126 days) then controlled hydralazine content drinking water (30 mg/l) (between 56 and 70 days) and hydralazine (50 mg/l) (between 56 and 70 days) and reserpine (4 mg/l) (between 56 and 70 days) |
Velasquez MT, et al., Hypertension. 1997 Nov;30(5):1232-7. |
blood glucose amount |
male |
140 days-168 days |
8 |
|
157.91 |
mg/dl |
34.49 |
97.54 |
serum glucose analysis |
0.0 |
|
0 |
|
|
101507 |
2601 |
SHR/N-cp |
serum glucose level |
standard diet (between 28 and 42 days) then controlled carbohydrate content diet (54 %) (between 84 and 98 days) then controlled hydralazine content drinking water (30 mg/l) (between 28 and 42 days) and hydralazine (50 mg/l) (between 28 and 42 days) and reserpine (4 mg/l) (between 28 and 42 days) |
Velasquez MT, et al., Hypertension. 1997 Nov;30(5):1232-7. |
blood glucose amount |
male |
112 days-140 days |
8 |
|
137.94 |
mg/dl |
30.86 |
87.27 |
serum glucose analysis |
0.0 |
|
0 |
|
|
101504 |
2601 |
LH/Mav |
systolic blood pressure |
hydralazine (75 mg/kg/d) (for 42 days) and controlled hydralazine content drinking water (15 mg/kg/d) (for 42 days) and reserpine (0.75 mg/kg/d) (for 42 days) |
Issiakhem M, et al., J Cardiovasc Pharmacol. 2008 Mar;51(3):280-5. doi: 10.1097/FJC.0b013e31816299a5. |
arterial blood pressure trait |
male |
63 days
| 10 |
undefined |
133.0 |
mmHg |
2.0 |
6.32 |
tail cuff plethysmography |
0.0 |
|
0 |
|
|
102852 |
2761 |
LH/Mav |
plasma total cholesterol level |
streptozotocin (75 mg/kg) then hydralazine (75 mg/kg/d) (for 56 days) and controlled hydralazine content drinking water (15 mg/kg/d) (for 56 days) and reserpine (0.75 ml/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
blood cholesterol amount |
male |
112 days
| 7 |
|
110.81 |
mg/dl |
4.25 |
11.24 |
blood cholesterol analysis |
0.0 |
|
0 |
|
|
102667 |
2703 |